Doxycycline to Protect Heart Muscle After Heart Attacks
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.
Also called NCT03508232
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT03508232
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT03508232. Randomized; quadruple masking; primary purpose prevention. Start 2020-01-06 (actual); primary completion 2025-07-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Doxycycline to Protect Heart Muscle After Heart Attacks
- Condition
- ST Segment Elevation Myocardial Infarction
- Condition
- Heart Failure
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Doxycycline Hyclate
- Lead sponsor
- University of Alberta
- Collaborator
- Royal Alexandra Hospital
Record details
- Record id
cardio:ct-nct03508232- Content hash
d5b89318c166e0f758be2b9988122bda556862f1bf91c7e41bd658fac074234b